FNA

Paragon 28 (FNA)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:FNA
DataOraFonteTitoloSimboloCompagnia
08/05/202422:05Business WireParagon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue GuidanceNYSE:FNAParagon 28 Inc
08/05/202422:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:FNAParagon 28 Inc
08/05/202422:01Edgar (US Regulatory)Form 8-K - Current reportNYSE:FNAParagon 28 Inc
02/05/202422:05Business WireParagon 28 to Present at the Bank of America Securities 2024 Healthcare ConferenceNYSE:FNAParagon 28 Inc
04/04/202414:01Business WireParagon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024NYSE:FNAParagon 28 Inc
28/03/202421:05Business WireParagon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair SystemNYSE:FNAParagon 28 Inc
08/03/202423:19Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:FNAParagon 28 Inc
02/03/202401:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:FNAParagon 28 Inc
01/03/202422:09Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:FNAParagon 28 Inc
29/02/202422:05Business WireParagon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue GuidanceNYSE:FNAParagon 28 Inc
29/02/202422:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:FNAParagon 28 Inc
14/02/202421:29Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:FNAParagon 28 Inc
12/02/202417:36Business WireParagon 28 to Present at the CG 2024 Musculoskeletal ConferenceNYSE:FNAParagon 28 Inc
06/02/202422:05Business WireParagon 28 To Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024NYSE:FNAParagon 28 Inc
01/02/202414:00Business WireParagon 28 Launches PRECISION® MIS Bunion System Offering Surgeons a Guided Minimally Invasive Surgical Solution for Treating Patients with BunionsNYSE:FNAParagon 28 Inc
30/01/202422:43Business WireParagon 28 Announces the Launch of the FJ2000™ Power Console and Burr System Designed Specifically for Foot and Ankle ProceduresNYSE:FNAParagon 28 Inc
26/01/202414:00Business WireParagon 28 Launches the Mister Tendon™ Harvester System – The First and Only Minimally Invasive Harvesting System for FHL and FDL Tendon Transfer ProceduresNYSE:FNAParagon 28 Inc
17/01/202414:00Business WireParagon 28 Announces First Cases and Limited Market Release of the Bun-Yo-Matic™ – A Next Generation Clamp and Cut Guide System for Lapidus Bunion ProceduresNYSE:FNAParagon 28 Inc
08/01/202415:00Business WireParagon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023NYSE:FNAParagon 28 Inc
05/01/202414:00Business WireParagon 28 Advances Foot and Ankle Specific Soft Tissue Portfolio with Launch of Grappler® Knotless Anchor System and Innovative Bridgeline™ TapeNYSE:FNAParagon 28 Inc
19/12/202322:05Business WireParagon 28 to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:FNAParagon 28 Inc
14/11/202322:05Business WireParagon 28 Launches BEAST™ Cortical Fibers Expanding its Biologics PortfolioNYSE:FNAParagon 28 Inc
14/11/202314:00Business WireParagon 28 Launches JAWS™ Great White Staple System Further Expanding its Nitinol Staple OfferingNYSE:FNAParagon 28 Inc
13/11/202322:05Business WireParagon 28 Adds Second Mobile Medical Education Lab Significantly Expanding Upon Wildly Successful Foot and Ankle Surgeon Training ProgramNYSE:FNAParagon 28 Inc
07/11/202322:05Business WireParagon 28 Announces New $150 Million Credit Facility Replacing Existing $90 Million Credit FacilityNYSE:FNAParagon 28 Inc
07/11/202322:05Business WireParagon 28 Reports Third Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue GuidanceNYSE:FNAParagon 28 Inc
03/11/202313:00Business WireParagon 28 to Present at Upcoming Investor ConferencesNYSE:FNAParagon 28 Inc
17/10/202322:05Business WireParagon 28 To Report Third Quarter Financial Results on November 7, 2023NYSE:FNAParagon 28 Inc
11/09/202313:00Business WireParagon 28®, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus™ System for use in Conjunction with the APEX 3D™ Total Ankle Replacement SystemNYSE:FNAParagon 28 Inc
28/08/202322:05Business WireParagon 28 to Present at the Morgan Stanley 21st Annual Global Healthcare ConferenceNYSE:FNAParagon 28 Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:FNA

La tua Cronologia

Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network